New in MMWR: COVID-19 Antiviral Treatment, Interim Flu Vaccine Effectiveness, and more

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]



MMWR banner

October 3, 2024

In this Issue

WEEKLY REPORT

The Graphic shows a bar chart representing the percentage of people who received COVID-19 antivirals by age group. Text reads, “Use of lifesaving COVID-19 treatment declines with increasing age. Older adults are at higher risk for hospitalization and death from COVID-19. Early antivirals reduce risk.”

Differences in COVID-19 Outpatient Antiviral Treatment Among Adults Aged ≥65 Years by Age Group

Fewer than one half of patients aged 65 and older with an outpatient COVID-19 diagnosis received COVID-19 treatment, and treatment declined with increasing age. Use of COVID-19 treatment was lowest among the oldest adults who would benefit most.

PDF of this issue (link)

CONTINUING EDUCATION

The photo shows a child with measles on their abdomen. Text reads, “Measles — United States, January 1, 2020-March 28, 2024. From MMWR and Medscape. Get your free CE.”

A new, free CE from MMWR and Medscape discusses U.S. measles cases that occurred from January 1, 2020 to March 28, 2024.

Centers for Disease Control and Prevention

1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348
Questions or Problems  | 


[Index of Archives]     [NIH News]     [FDA News]     [USDA News]     [Yosemite News]     [Steve's Art]     [SB Lupus]     [STB]
  Powered by Linux